MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-11-30, BMRA had -$510K decrease in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
-$510K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-11-30
2025-08-31
2025-05-31
Net loss
-1,320 2 -4,973
Depreciation and amortization
20 20 87
Provision for allowance for credit losses
32 38 8
Inventory reserve
-44 7 4
Share-based compensation
117 133 460
Amortization of right-of-use asset
83 82 313
Accounts receivable
-227 512 -209
Inventories
8 -10 -882
Prepaid expenses and other
9 -87 17
Other assets
-11 -5 -8
Accounts payable and accrued expenses
60 10 -466
Accrued compensation
-47 -63 1
Advances from customers
-24 -1 -30
Reduction in lease liabilities
-89 -86 -327
Net cash used in operating activities
-991 -268 -3,841
Purchases of property and equipment
--0
Expenditures related to intangibles
--37
Net cash used in investing activities
---37
Gross proceeds from sale of common stock
493 939 2,143
Deferred offering costs
--3
Costs from sale of common stock
11 19 44
Proceeds from exercise of stock options
--15
Net cash provided by financing activities
482 920 2,111
Effect of exchange rate changes on cash
-1 2 -3
Net increase (decrease) in cash and cash equivalents
-510 654 -1,770
Cash and cash equivalents at beginning of period
3,053 2,399 -
Cash and cash equivalents at end of period
2,543 3,053 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

BIOMERICA INC (BMRA)

BIOMERICA INC (BMRA)